Colombia's move to cut cancer drug's price draws criticism
A new move by Colombia to force a leading drugmaker to discount a cancer drug is quickly becoming a flash point in the long-running battle between those wanting more protection for...To view the full article, register now.
Already a subscriber? Click here to view full article